Dalteparin Sodium
CAS No.: 9041-08-1 (Low molecular weight heparin)

Short Description:

Source: Extracted from porcine intestinal mucosa and degraded by sodium nitrite.

Function and use: Dalteparin sodium is a low molecular weight heparin sodium, which is used for anticoagulation by promoting the inhibitory effect of antithrombin on coagulation factor Xa and thrombin. Dalteparin sodium mainly potentiates the inhibition of coagulation factor Xa, while slightly prolonging the activated partial thromboplastin time (APTT). For the treatment of acute deep vein thrombosis; prevention of coagulation in the extracorporeal circulation system during hemodialysis and hemofiltration in patients with acute renal failure or chronic renal insufficiency; treatment of unstable coronary artery disease such as unstable angina and non-Q Wave myocardial infarction; prevention of surgery-related thrombosis.

Dalteparin Sodium-Pharmacopoeia Standard: USP/EP

product-description1


Product Detail

Product Tags

Specification

Dalteparin Sodium
Source Intestinal mucosa of pigs
Quality standard

USP

EP

characters

Appearance

/

white or almost white; hygroscopic powder
solubility

/

freely soluble in water
identification

1H NMR SPECTRUM :The ppm values for the methyl group

of N-acetyl, the H-2 of N-sulfo glucosamine, the H-2 of

glucuronic acid plus 3-O-sulfo glucosamine, the H-1 of

iduronic acid, the H-1 of the 2-O-sulfo iduronic acid linked

to the terminal anhydromannitol and the H-1 of 2-O-sulfo

iduronic acid, and the H-1 of 3-O-sulfo glucosamine of

dalteparin in the Sample solution are present at 2.05, 3.28,

3.39, 5.01, 5.18–5.22, and 5.51, respectively. The ppm

values of these signals do not differ by more than

±0.03 ppm.

The 13C NMR spectrum obtained is similar to that obtained with the appropriate specific dalteparin sodium CRS

Mw : 5600 -6400Da, M≤3000 : NMT 13.0%,M≥8000:15.0%-25.0%

Mw : 5600 -6400Da, M≤3000 : NMT 13.0%,M≥8000:15.0%-25.0%

Anti-factor Xa activity/ anti- factor IIa : 1.9-3.2

Anti- factor Xa activity/ anti- factor IIa : 1.9-3.2

It complies with the test for sodium

It complies with the test for sodium
Appearance of solution /

The solution is clear (2.2.1) and not more intensely coloured than intensity 5 of the range of reference solutions of the most appropriate colour (2.2.2, Method II).

pH

5.5-8.0

5.5-8.0

Molar ratio of Sulfate carboxylate ≥1.8 ≥ 1.8
Nitrogen

1.5 %-2.5 % (on the dried basis)

1.5 %-2.5 % (on the dried basis)

Sodium 10.5% -13.5% (on the dried basis)

10.5% -13.5% (on the dried basis)

Nitrite

≤ 5ppm

≤ 5ppm

Loss on drying

≤10.0%

≤5.0%

Bacterial endotoxins

<0.01EU/U

<0.01EU/IU

Boron

≤1ppm

≤ 1ppm

Assay Anti- factor Xa activity

110-210 IU/mg (on the dried basis)

110-210 IU/mg (on the dried basis)

Anti- factor IIa activity

35-100 IU/mg (on the dried basis)

35-100 IU/mg (on the dried basis)

Indications

Treat acute deep vein thrombosis.
Prevent coagulation in the extracorporeal circulation system during hemodialysis and blood filtration in patients with acute renal failure or chronic renal insufficiency.
Treat unstable coronary artery diseases, such as unstable angina and non Q-wave myocardial infarction.
Prevent thrombosis related to surgery.


  • Previous:
  • Next:

  • Write your message here and send it to us